Emanuela Taioli, MD, PhD, on Disparities in Early-Stage Lung Cancer Diagnosis
Given that diagnosing lung cancer in its early stages can lead to successfully eliminating lung cancer with surgery alone, the importance of closing this disparity gap is critical.
Researchers at Mount Sinai have shown that early CT screening for lung cancer leads to early diagnosis and treatment, thus saving lives.
However, Mount Sinai researchers also identified racial disparities in the diagnosis of early-stage lung cancer. Given that diagnosing lung cancer in its early stages can lead to successfully eliminating lung cancer with surgery alone, the importance of closing this observed disparity gap is critical.
In an interview with CancerNetwork®, Emanuela Taioli, MD, PhD, director of the Institute for Translational Epidemiology at Mount Sinai, discussed the racial disparities in the diagnosis of early-stage lung cancer that she and her colleagues identified as well as programs that have been initiated to help close this disparity gap.
This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs
Read about a woman with well-differentiated atypical carcinoid who experienced a 21% regression in primary tumor size after 12 months on neoadjuvant capecitabine and temozolomide.
